-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M4SGnqwOT7GpVOyy5Bhb58S79PiytEhgxcLYVTOnMGRfYtsYztn69nOEkfTEE4eS dkmda8x+zbPRyz+3ugGKbg== 0001144204-08-030524.txt : 20080516 0001144204-08-030524.hdr.sgml : 20080516 20080516180229 ACCESSION NUMBER: 0001144204-08-030524 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080507 FILED AS OF DATE: 20080516 DATE AS OF CHANGE: 20080516 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ardea Biosciences, Inc./DE CENTRAL INDEX KEY: 0001103390 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943200380 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2131 PALOMAR ROAD STREET 2: SUITE 300 CITY: CARLSBAD STATE: CA ZIP: 92011 BUSINESS PHONE: 760-602-8422 MAIL ADDRESS: STREET 1: 2131 PALOMAR ROAD STREET 2: SUITE 300 CITY: CARLSBAD STATE: CA ZIP: 92011 FORMER COMPANY: FORMER CONFORMED NAME: INTRABIOTICS PHARMACEUTICALS INC /DE DATE OF NAME CHANGE: 20000127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAKER FELIX CENTRAL INDEX KEY: 0001087940 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33734 FILM NUMBER: 08843517 BUSINESS ADDRESS: STREET 1: TISCH FAMILY INTERESTS STREET 2: 667 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 212-339-5600 MAIL ADDRESS: STREET 1: BAKER BROTHERS ADVISORS STREET 2: 667 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAKER JULIAN CENTRAL INDEX KEY: 0001087939 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33734 FILM NUMBER: 08843518 BUSINESS ADDRESS: STREET 1: TISCH FAMILY INTERESTS STREET 2: 667 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 212-339-5600 MAIL ADDRESS: STREET 1: BAKER BROTHERS ADVISORS STREET 2: 667 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baker Biotech Capital (GP), LLC CENTRAL INDEX KEY: 0001244389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33734 FILM NUMBER: 08843519 BUSINESS ADDRESS: STREET 1: 667 MADISON AVE 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 212-339-5600 MAIL ADDRESS: STREET 1: 667 MADISON AVE 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 FORMER NAME: FORMER CONFORMED NAME: BAKER BIOTECH CAPITAL GP LLC DATE OF NAME CHANGE: 20030619 4 1 form415756_051608180116-.xml X0202 4 2008-05-07 0 0001103390 Ardea Biosciences, Inc./DE RDEA 0001244389 Baker Biotech Capital (GP), LLC 667 MADISON AVENUE, 17TH FLOOR NEW YORK NY US 10021 0 0 1 0 0001087939 BAKER JULIAN 667 MADISON AVENUE, 17TH FLOOR NEW YORK NY US 10021 0 0 1 0 0001087940 BAKER FELIX 667 MADISON AVENUE, 17TH FLOOR NEW YORK NY US 10021 0 0 1 0 Common Stock 2008-05-07 4 C 0 294624 A 1462184 I Through Partnership Series A Convertible Preferred 2008-05-07 4 C 0 56 0 D 2003-05-01 Common Stock 294624 0 I Through Partnership In addition to Baker Biotech Capital (GP), LLC, this Form 4 is being filed jointly by Julian C. Baker and Felix J. Baker, each of whom has the same business address as Baker Biotech Capital (GP), LLC and may be deemed to have a pecuniary interest in securities owned by it. Because of certain relationships with other security holders of the Issuer, the Reporting Persons are filing solely for informational purposes as if they were members of a group of such shareholders. (Continued in footnote 2). However, the Reporting Persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, or Rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein. Represents securities owned directly by Baker Biotech Fund I, L.P., the sole general partner of which is Baker Biotech Capital, L.P., a limited partnership the sole general partner of which is Baker Biotech Capital (GP),LLC. Julian C. Baker and Felix J. Baker are the controlling members of Baker Biotech Capital (GP), LLC. Each shares of Series A Convertible Preferred Stock was convertible into a number of shares of common stock equal to $10,000 divided by $1.90072. None. /s/ Julian C. Baker, as Managing Member of Baker Biotech Capital (GP), LLC 2008-05-16 /s/ Julian C. Baker 2008-05-16 /s/ Felix J. Baker 2008-05-16 -----END PRIVACY-ENHANCED MESSAGE-----